Seer, Inc. (SEER) Reports Q2 Loss, Beats Revenue Estimates

Group 1: Earnings Performance - Seer, Inc. reported a quarterly loss of $0.33 per share, better than the Zacks Consensus Estimate of a loss of $0.39, and compared to a loss of $0.35 per share a year ago, representing an earnings surprise of +15.38% [1] - The company posted revenues of $4.05 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 8.90%, and up from $3.07 million in the same quarter last year [2] - Over the last four quarters, Seer has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Group 2: Stock Performance and Outlook - Seer shares have declined approximately 8.2% since the beginning of the year, while the S&P 500 has gained 7.1% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.19 on revenues of $4.32 million, and for the current fiscal year, it is -$1.05 on revenues of $17.54 million [7] - The estimate revisions trend for Seer was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Group 3: Industry Context - The Medical - Biomedical and Genetics industry, to which Seer belongs, is currently ranked in the bottom 42% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]